Skip to content
Screener

MapLight Therapeutics, Inc. MPLT Total Assets

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$87.63B-7.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$201.06B+4.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$4.91B+33.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$1.74B+42.2%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
LBR
LB Pharmaceuticals IncLBRX
$393.48M—

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M—
Total debt$5.6M—
Total equity$399.8M+285%

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K—
Free cash flow-$51.2M—

Valuation

See full
Market cap$551.86M-20.5%
Enterprise value$501.74M—

Returns & leverage

See full
Return on equity-216.8%—
Debt / equity0×—
Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:25 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224129
Line itemMarch 31, 2026December 31, 2025
Restricted cash207207
Right-of-use asset5,2595,488
Other assets3659
Total assets$418,788$479,512
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable$3,188$3,289
Accrued expenses10,17512,049

Item 1. Financial Statements.

FAQ

What is MapLight Therapeutics, Inc.'s total assets?
MapLight Therapeutics, Inc. (MPLT) reported total assets of $418.79M in Q1 2026.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about MapLight Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude